Haemonetics HAE Deferred Tax Assets
Deferred Tax Assets at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxLiabilitiesNet.
The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Haemonetics's deferred tax assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Haemonetics's deferred tax assets?
- Haemonetics (HAE) reported deferred tax assets of $38.05M in Q1 2026.
- How has Haemonetics's deferred tax assets changed year-over-year?
- Haemonetics's deferred tax assets decreased by 39.2% year-over-year, from $62.58M to $38.05M.
- What is the long-term trend for Haemonetics's deferred tax assets?
- Over 5 years (2021 to 2026), Haemonetics's deferred tax assets has grown at a -2.8% compound annual growth rate (CAGR), from $43.83M to $38.05M.
- What does deferred tax assets mean?
- Future tax benefits from temporary differences, net operating loss carryforwards, and tax credit carryforwards that will reduce future tax payments.